TCBPW | TC Biopharm (Holdings) Plc Annual & Quarterly

Annual Income Statements

(In GBP)

Breakdown	2023	2022	2021	2020	2019
Revenue	-	3.84 Million	1.97 Million	1.97 Million	3.42 Million
Cost of Revenue	-	-	-	-	-
Gross Profit	-	3.84 Million	1.97 Million	1.97 Million	3.42 Million
Operating Expenses	6.91 Million	124.9 Thousand	13.52 Million	8.31 Million	10.06 Million
Selling, General and Administrative Expenses	6.87 Million	8.73 Million	3.1 Million	2.2 Million	3.01 Million
Research and Development Expenses	7.77 Million	7.59 Million	6.15 Million	6.67 Million	8.61 Million
Other Expenses	-	-	-	-	-
Cost and Expenses	6.91 Million	124.9 Thousand	13.52 Million	8.31 Million	10.06 Million
Operating Income	-14.23 Million	-12.08 Million	-7.28 Million	-6.88 Million	-6.64 Million
Interest Expense	-	6.75 Million	3.43 Million	292.06 Thousand	275.41 Thousand
Income Tax Expense	-1.08 Million	1.72 Million	1.4 Million	1.17 Million	826.06 Thousand
Earnings before Tax	-6.99 Million	-3.03 Million	-14.98 Million	-6.62 Million	-6.89 Million
Net Income	-5.9 Million	-1.31 Million	-13.57 Million	-5.45 Million	-6.06 Million
Earnings Per Share Basic	-191.21	-382.31	-6951.59	-2884.12	-
Earnings Per Share Diluted	-191.21	-382.31	-6951.59	-2884.12	-
Weighted Average Shares Outstanding	30.89 Thousand	3436.00	1952.92	1892.40	1892.40
Weighted Average Shares Outstanding (Diluted)	30.89 Thousand	3436.00	1952.92	1892.40	1892.40
Gross Margin	-	1.00	1.00	1.00	1.00
EBIT Margin	-	-2.94	-3.27	-3.04	-1.73
Profit Margin	-	-0.34	-6.86	-2.76	-1.77
EBITDA	-13.6 Million	-11.32 Million	-6.47 Million	-5.26 Million	-5.91 Million
Earnings Before Tax Margin	-	-3.14	-3.68	-3.48	-1.94

Breakdown	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2	2023 Q1
Revenue	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expenses	3.43 Million	6.91 Million	3.35 Million	3.35 Million	129 Thousand	1.03 Million
Selling, General and Administrative Expenses	2.14 Million	-	1.63 Million	1.63 Million	2.29 Million	2.23 Million
Research and Development Expenses	1.29 Million	-	1.84 Million	1.84 Million	2.58 Million	1.93 Million
Other Expenses	-2386.00	-	-	-	-	-
Cost and Expenses	3.43 Million	6.91 Million	3.35 Million	3.35 Million	129 Thousand	1.03 Million
Operating Income	-3.44 Million	-14.23 Million	-3.27 Million	-3.27 Million	-4.88 Million	-4.18 Million
Interest Expense	-	-	-	-	-	-
Income Tax Expense	110.74 Thousand	1.08 Million	194.36 Thousand	194.36 Thousand	444.48 Thousand	400 Thousand
Earnings before Tax	-3.43 Million	-6.99 Million	-3.32 Million	-3.32 Million	-219.96 Thousand	-1.03 Million
Net Income	-3.32 Million	-5.9 Million	-3.13 Million	-3.13 Million	224.51 Thousand	-634.91 Thousand
Earnings Per Share Basic	-22.04	-	-67.13	-67.13	12.70	-61.89
Earnings Per Share Diluted	-22.04	-	-67.13	-67.13	12.87	-61.89
Weighted Average Shares Outstanding	150.69 Thousand	30.89 Thousand	46.63 Thousand	46.63 Thousand	17.67 Thousand	10.25 Thousand
Weighted Average Shares Outstanding (Diluted)	150.69 Thousand	30.89 Thousand	46.63 Thousand	46.63 Thousand	17.44 Thousand	10.25 Thousand
Gross Margin	-	-	-	-	-	-
EBIT Margin	-	-	-	-	-	-
Profit Margin	-	-	-	-	-	-
EBITDA	-3.31 Million	-	-3.13 Million	-3.13 Million	-4.66 Million	-4 Million
Earnings Before Tax Margin	-	-	-	-	-	-